lunes, 6 de junio de 2016

Improving the Search for Biomarkers of Early Cancer



06/03/2016 10:26 PM EDT
The NCI's Early Detection Research Network (EDRN) is
an investigator-initiated infrastructure to support development
and validation of early cancer detection biomarkers and
markers of cancer progression. EDRN fosters interaction
between academic, clinical and industrial leaders; standardizes
biomarker validation criteria; develops a quality assurance
program; and brings biomarkers to clinical use. More
information is available at: edrn.cancer.gov and
prevention.cancer.gov.

No hay comentarios:

Publicar un comentario